GlassScriptPhysician profile
Douglas A Tomasian
NPI 1922187756
$11,970.73
in general payments reported to CMS, 2019-2025
48 companies · $1,730 in 2025
The $1,730 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,766 · 2020: $937 · 2021: $1,770 · 2022: $1,732 · 2023: $1,415 · 2024: $1,621 · 2025: $1,730.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,579 · Education: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,578.82 |
| Education | $187.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $3,290.03 | 2019-2024 | Nhancer Rx, Biomonitor, Orsiro Mission |
| E.R. Squibb & Sons, L.L.C. | $1,028.60 | 2020-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $785.22 | 2020-2025 | Cardiomems, Navitor, Aveir |
| Boston Scientific Corporation | $748.94 | 2019-2025 | Watchman Flx, Stingray, Rhythmia Mapping System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $714.16 | 2020-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $629.52 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $422.59 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $368.48 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Bard Peripheral Vascular, INC. | $363.75 | 2021-2024 | Rotarexs 6 F X 135 Cm |
| Medtronic, INC. | $336.94 | 2021-2024 | Abre, Corevalve Evolut R |
| Amarin Pharma, INC. | $322.64 | 2020-2021 | |
| Heartflow, INC. | $273.72 | 2024-2025 | |
| Amgen INC. | $252.92 | 2019-2024 | Repatha |
| Abiomed | $251.73 | 2019-2025 | Impella |
| Merck Sharp & Dohme LLC | $203.99 | 2021-2025 | Verquvo |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $196.42 | 2020-2024 | Nexletol |
| Astellas Pharma US INC | $185.50 | 2019-2023 | |
| Stryker Corporation | $179.86 | 2025 | Artix Mt, Inthrill Thrombectomy Catheter, Flowtriever |
| Edwards Lifesciences Corporation | $168.31 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Ge Healthcare | $107.65 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $92.57 | 2024-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $89.51 | 2023-2024 | Optimizer, Optimizer |
| Astrazeneca Pharmaceuticals LP | $79.38 | 2020-2024 | Farxiga |
| Pfizer INC. | $74.51 | 2021-2024 | |
| Cardiovascular Systems INC. | $65.86 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $60.81 | 2022-2024 | Onpattro |
| Angiodynamics, INC. | $55.68 | 2021 | |
| Terumo Medical Corporation | $54.54 | 2021-2023 | Heartrail, Glidewire, Metacross Otw |
| Bayer Healthcare Pharmaceuticals INC. | $54.27 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $47.36 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $43.46 | 2022 | |
| Intuitive Surgical, INC. | $37.26 | 2024 | |
| Surmodics, INC. | $36.61 | 2023-2024 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Baxter Healthcare | $33.24 | 2023-2025 | Biopharma Sol - Contract Manuf |
| Glaxosmithkline, LLC. | $33.19 | 2025 | Shingrix, Arexvy |
| Medtronic Vascular, INC. | $32.04 | 2020 | |
| Thrombolex, INC. | $29.53 | 2023 | |
| Cvrx, INC. | $28.58 | 2025 | Barostim Neo System |
| Bardy Diagnostics, INC. | $26.98 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $24.97 | 2024 | Arcalyst |
| Lilly USA, LLC | $24.59 | 2025 | Zepbound, Mounjaro |
| Recor Medical INC | $21.00 | 2025 | Paradise Ultrasound Renal Denervation System |
| Inspire Medical Systems, INC. | $18.74 | 2023 | Inspire |
| Cordis US Corp. | $16.89 | 2024 | Mynx Venous Vcd |
| Sanofi-Aventis U.S. LLC | $16.88 | 2021 | |
| Cardinal Health 200 LLC | $14.74 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $13.37 | 2021 | |
| Scpharmaceuticals INC. | $13.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Tomasian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.